Related Experiment Video

Updated: May 10, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

Therapeutic vaccines for ovarian cancer

John B Liao1, Mary L Disis

  • 1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, 1959 NE Pacific St., Seattle, WA 98195, USA.

Gynecologic Oncology
|June 27, 2013
PubMed

Insights

Therapeutic vaccines show promise for ovarian cancer treatment. Ongoing research and clinical trials are expanding their use, with future strategies targeting the tumor microenvironment to improve vaccine efficacy.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Therapeutic vaccines for ovarian cancer are an emerging area of research.
  • Growing evidence supports vaccine-based strategies in cancer therapy.

Purpose of the Study:

  • To review the rationale and current data for using vaccines in ovarian cancer treatment.
  • To examine investigated vaccine platforms and clinical trial outcomes.
  • To explore future directions for ovarian cancer vaccines.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of data from phase 2 and 3 clinical trials.
  • Discussion of emerging strategies targeting the tumor microenvironment.

Main Results:

  • Vaccine platforms for ovarian cancer have been investigated with varying results.
  • Recent phase 2 and 3 trials provide clinical outcome data.
  • The tumor microenvironment presents challenges and opportunities for vaccine development.

Conclusions:

  • Therapeutic vaccines hold potential for ovarian cancer treatment.
  • Further research is needed to optimize vaccine strategies.
  • Targeting the immunosuppressive tumor microenvironment may enhance vaccine effectiveness.
Keywords:
Immune therapiesOvarian cancerVaccines

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...